Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer's disease, suspected-LATE and frontotemporal dementia.
Humans
Frontotemporal Dementia
/ diagnostic imaging
Male
Locus Coeruleus
/ diagnostic imaging
Alzheimer Disease
/ diagnostic imaging
Female
Aged
Magnetic Resonance Imaging
/ methods
Basal Nucleus of Meynert
/ diagnostic imaging
Middle Aged
Neuropsychological Tests
Amnesia
/ diagnostic imaging
Positron-Emission Tomography
/ methods
Alzheimer
FTD
LATE
Locus coeruleus
MRI
Nucleus basalis of Meynert
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
received:
23
12
2023
accepted:
25
04
2024
medline:
4
5
2024
pubmed:
4
5
2024
entrez:
3
5
2024
Statut:
epublish
Résumé
The locus coeruleus (LC) and the nucleus basalis of Meynert (NBM) are altered in early stages of Alzheimer's disease (AD). Little is known about LC and NBM alteration in limbic-predominant age-related TDP-43 encephalopathy (LATE) and frontotemporal dementia (FTD). The aim of the present study is to investigate in vivo LC and NBM integrity in patients with suspected-LATE, early-amnestic AD and FTD in comparison with controls. Seventy-two participants (23 early amnestic-AD patients, 17 suspected-LATE, 17 FTD patients, defined by a clinical-biological diagnosis reinforced by amyloid and tau PET imaging, and 15 controls) underwent neuropsychological assessment and 3T brain MRI. We analyzed the locus coeruleus signal intensity (LC-I) and the NBM volume as well as their relation with cognition and with medial temporal/cortical atrophy. We found significantly lower LC-I and NBM volume in amnestic-AD and suspected-LATE in comparison with controls. In FTD, we also observed lower NBM volume but a slightly less marked alteration of the LC-I, independently of the temporal or frontal phenotype. NBM volume was correlated with the global cognitive efficiency in AD patients. Strong correlations were found between NBM volume and that of medial temporal structures, particularly the amygdala in both AD and FTD patients. The alteration of LC and NBM in amnestic-AD, presumed-LATE and FTD suggests a common vulnerability of these structures to different proteinopathies. Targeting the noradrenergic and cholinergic systems could be effective therapeutic strategies in LATE and FTD.
Sections du résumé
BACKGROUND
BACKGROUND
The locus coeruleus (LC) and the nucleus basalis of Meynert (NBM) are altered in early stages of Alzheimer's disease (AD). Little is known about LC and NBM alteration in limbic-predominant age-related TDP-43 encephalopathy (LATE) and frontotemporal dementia (FTD). The aim of the present study is to investigate in vivo LC and NBM integrity in patients with suspected-LATE, early-amnestic AD and FTD in comparison with controls.
METHODS
METHODS
Seventy-two participants (23 early amnestic-AD patients, 17 suspected-LATE, 17 FTD patients, defined by a clinical-biological diagnosis reinforced by amyloid and tau PET imaging, and 15 controls) underwent neuropsychological assessment and 3T brain MRI. We analyzed the locus coeruleus signal intensity (LC-I) and the NBM volume as well as their relation with cognition and with medial temporal/cortical atrophy.
RESULTS
RESULTS
We found significantly lower LC-I and NBM volume in amnestic-AD and suspected-LATE in comparison with controls. In FTD, we also observed lower NBM volume but a slightly less marked alteration of the LC-I, independently of the temporal or frontal phenotype. NBM volume was correlated with the global cognitive efficiency in AD patients. Strong correlations were found between NBM volume and that of medial temporal structures, particularly the amygdala in both AD and FTD patients.
CONCLUSIONS
CONCLUSIONS
The alteration of LC and NBM in amnestic-AD, presumed-LATE and FTD suggests a common vulnerability of these structures to different proteinopathies. Targeting the noradrenergic and cholinergic systems could be effective therapeutic strategies in LATE and FTD.
Identifiants
pubmed: 38702802
doi: 10.1186/s13195-024-01466-z
pii: 10.1186/s13195-024-01466-z
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
97Informations de copyright
© 2024. The Author(s).
Références
Ehrenberg AJ, Kelberman MA, Liu KY, et al. Priorities for research on neuromodulatory subcortical systems in Alzheimer’s disease: position paper from the NSS PIA of ISTAART. Alzheimers Dement. 2023;19(5):2182–96.
pubmed: 36642985
doi: 10.1002/alz.12937
Matchett BJ, Grinberg LT, Theofilas P, et al. The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease. Acta Neuropathol. 2021;141(5):631–50.
pubmed: 33427939
pmcid: 8043919
doi: 10.1007/s00401-020-02248-1
Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009;10:211–23.
pubmed: 19190638
doi: 10.1038/nrn2573
Šimić G, Babić Leko M, Wray S, et al. Monoaminergic neuropathology in Alzheimer’s disease. Prog Neurobiol. 2017;151:101–38.
pubmed: 27084356
doi: 10.1016/j.pneurobio.2016.04.001
Baxter MG, Chiba AA. Cognitive functions of the basal forebrain. Curr Opin Neurobiol. 1999;9:178–83.
pubmed: 10322180
doi: 10.1016/S0959-4388(99)80024-5
Sarter M, Bruno JP, Givens B. Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiol Learn Mem. 2003;80:245–56.
pubmed: 14521867
doi: 10.1016/S1074-7427(03)00070-4
Grudzien A, Shaw P, Weintraub S, et al. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging. 2007;28:327–35.
pubmed: 16574280
doi: 10.1016/j.neurobiolaging.2006.02.007
Arendt T, Brückner MK, Morawski M, et al. Early neurone loss in Alzheimer’s disease: cortical or subcortical? Acta Neuropathol Commun. 2015;3:10.
pubmed: 25853173
pmcid: 4359478
doi: 10.1186/s40478-015-0187-1
Kelly SC, He B, Perez SE, et al. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease. Acta Neuropathol Commun. 2017;5:8.
pubmed: 28109312
pmcid: 5251221
doi: 10.1186/s40478-017-0411-2
Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet. 1976;2:1403.
pubmed: 63862
doi: 10.1016/S0140-6736(76)91936-X
Whitehouse PJ, Price DL, Clark AW, et al. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981;10:122–6.
pubmed: 7283399
doi: 10.1002/ana.410100203
Hall AM, Moore RY, Lopez OL, et al. Basal forebrain atrophy is a presymptomatic marker for Alzheimer’s disease. Alzheimers Dement. 2008;4:271–9.
pubmed: 18631978
doi: 10.1016/j.jalz.2008.04.005
Grothe M, Zaborszky L, Atienza M, et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer’s disease. Cereb Cortex. 2010;20:1685–95.
pubmed: 19889714
doi: 10.1093/cercor/bhp232
Mesulam M, Shaw P, Mash D, et al. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol. 2004;55:815–28.
pubmed: 15174015
doi: 10.1002/ana.20100
Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain. 2015;138(Pt 10):2814–33.
pubmed: 26283673
doi: 10.1093/brain/awv236
Braak H, Thal DR, Ghebremedhin E, et al. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70:960–9.
pubmed: 22002422
doi: 10.1097/NEN.0b013e318232a379
Braak H, Del Tredici K. Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol. 2011;121:589–95.
pubmed: 21516512
doi: 10.1007/s00401-011-0825-z
Braak H, Del Tredici K. Where, when, and in what form does sporadic Alzheimer’s disease begin? Curr Opin Neurol. 2012;25:708–14.
pubmed: 23160422
doi: 10.1097/WCO.0b013e32835a3432
Weinshenker D. Long Road to ruin: noradrenergic dysfunction in neurodegenerative disease. Trends Neurosci. 2018;41(4):211–23.
pubmed: 29475564
pmcid: 5878728
doi: 10.1016/j.tins.2018.01.010
Betts MJ, Kirilina E, Otaduy MCG, et al. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 2019;142(9):2558–71.
pubmed: 31327002
pmcid: 6736046
doi: 10.1093/brain/awz193
Teipel SJ, Flatz WH, Heinsen H, et al. Measurement of basal forebrain atrophy in Alzheimer’s disease using MRI. Brain. 2005;128:2626–44.
pubmed: 16014654
doi: 10.1093/brain/awh589
Zaborszky L, Hoemke L, Mohlberg H, et al. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. NeuroImage. 2008;42:1127–41.
pubmed: 18585468
doi: 10.1016/j.neuroimage.2008.05.055
Grothe MJ, Schuster C, Bauer F, et al. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer’s disease dementia. J Neurol. 2014;261:1939–48.
pubmed: 25059393
doi: 10.1007/s00415-014-7439-z
Grothe M, Heinsen H, Teipel SJ. Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer’s disease. Biol Psychiatry. 2012;71:805–13.
pubmed: 21816388
doi: 10.1016/j.biopsych.2011.06.019
Teipel SJ, Meindl T, Grinberg L, et al. The cholinergic system in mild cognitive impairment and Alzheimer’s disease: an in vivo MRI and DTI study. Hum Brain Mapp. 2011;32:1349–62.
pubmed: 20672311
doi: 10.1002/hbm.21111
Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503–27.
pubmed: 31039256
pmcid: 6536849
doi: 10.1093/brain/awz099
Nelson PT, Lee EB, Cykowski MD, et al. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathol. 2023;145(2):159–73.
pubmed: 36512061
doi: 10.1007/s00401-022-02524-2
Nag S, Schneider JA. Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases. Nat Rev Neurol. 2023;19(9):525–41.
pubmed: 37563264
pmcid: 10964248
doi: 10.1038/s41582-023-00846-7
Teipel SJ, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology. Eur J Neurol. 2022;29:1394–401.
pubmed: 35122358
doi: 10.1111/ene.15270
Teipel S, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer’s disease pathology. Neurobiol Dis. 2023;180:106070.
pubmed: 36898615
doi: 10.1016/j.nbd.2023.106070
Ohm DT, Peterson C, Lobrovich R, et al. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum. Acta Neuropathol. 2020;140:675–93.
pubmed: 32804255
pmcid: 7554264
doi: 10.1007/s00401-020-02210-1
Matti N, Javanshiri K, Haglund M, Saenz-Sardá X, Englund E. Locus Coeruleus Degeneration differs between Frontotemporal Lobar Degeneration subtypes. J Alzheimers Dis. 2022;89(2):463–71.
pubmed: 35871340
pmcid: 9535600
doi: 10.3233/JAD-220276
Convery RS, Neason MR, Cash DM, et al. Basal forebrain atrophy in frontotemporal dementia. Neuroimage Clin. 2020;26:102210.
pubmed: 32143137
pmcid: 7058403
doi: 10.1016/j.nicl.2020.102210
Lagarde J, Olivieri P, Tonietto M, et al. Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type. Transl Psychiatry. 2021;11(1):498.
pubmed: 34588422
pmcid: 8481505
doi: 10.1038/s41398-021-01628-9
Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456–77.
pubmed: 21810890
pmcid: 3170532
doi: 10.1093/brain/awr179
Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–14.
pubmed: 21325651
pmcid: 3059138
doi: 10.1212/WNL.0b013e31821103e6
Lagarde J, Olivieri P, Tonietto M, et al. Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2022;93(5):459–67.
pubmed: 35228270
doi: 10.1136/jnnp-2021-328623
García-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain. 2013;136:2120–9.
pubmed: 23801736
pmcid: 3692035
doi: 10.1093/brain/awt152
Shibata E, Sasaki M, Tohyama K, et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci. 2006;5:197–200.
pubmed: 17332710
doi: 10.2463/mrms.5.197
Olivieri P, Lagarde J, Lehericy S, et al. Early alteration of the locus coeruleus in phenotypic variants of Alzheimer’s disease. Ann Clin Transl Neurol. 2019;6:1345–51.
pubmed: 31353860
pmcid: 6649639
doi: 10.1002/acn3.50818
Tustison NJ, Avants BB, Cook PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29:1310–20.
pubmed: 20378467
pmcid: 3071855
doi: 10.1109/TMI.2010.2046908
Manjón JV, Coupé P, volBrain. An online MRI brain Volumetry System. Front Neuroinform. 2016;10:30.
pubmed: 27512372
pmcid: 4961698
doi: 10.3389/fninf.2016.00030
Eickhoff SB, Stephan KE, Mohlberg H, et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage. 2005;25:1325–35.
pubmed: 15850749
doi: 10.1016/j.neuroimage.2004.12.034
Jack CR Jr, Wiste HJ, Weigand SD, et al. Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimers Dement. 2017;13(3):205–16.
pubmed: 27697430
doi: 10.1016/j.jalz.2016.08.005
Ossenkoppele R, Lyoo CH, Sudre CH, et al. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease. Alzheimers Dement. 2020;16(2):335–44.
pubmed: 31672482
doi: 10.1016/j.jalz.2019.08.201
Geula C, Dunlop SR, Ayala I, et al. Basal forebrain cholinergic system in the dementias: vulnerability, resilience, and resistance. J Neurochem. 2021;158(6):1394–411.
pubmed: 34272732
pmcid: 8458251
doi: 10.1111/jnc.15471
Kilimann I, Grothe M, Heinsen H, et al. Subregional basal forebrain atrophy in Alzheimer’s disease: a multicenter study. J Alzheimers Dis. 2014;40:687–700.
pubmed: 24503619
pmcid: 4120953
doi: 10.3233/JAD-132345
Galgani A, Giorgi FS. Exploring the role of Locus Coeruleus in Alzheimer’s Disease: a Comprehensive Update on MRI studies and implications. Curr Neurol Neurosci Rep. 2023;23(12):925–36.
pubmed: 38064152
pmcid: 10724305
doi: 10.1007/s11910-023-01324-9
Jacobs HIL, Becker JA, Kwong K, et al. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline. Sci Transl Med. 2021;13(612):eabj2511.
pubmed: 34550726
pmcid: 8641759
doi: 10.1126/scitranslmed.abj2511
Fernández-Cabello S, Kronbichler M, Van Dijk KRA, et al. Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degeneration. Brain. 2020;143(3):993–1009.
pubmed: 32203580
pmcid: 7092749
doi: 10.1093/brain/awaa012
Galgani A, Lombardo F, Martini N, et al. Magnetic resonance imaging Locus Coeruleus abnormality in amnestic mild cognitive impairment is associated with future progression to dementia. Eur J Neurol. 2023;30(1):32–46.
pubmed: 36086917
doi: 10.1111/ene.15556
Cykowski MD, Takei H, Van Eldik LJ, et al. Hippocampal sclerosis but not normal aging or Alzheimer Disease is Associated with TDP-43 Pathology in the basal forebrain of aged persons. J Neuropathol Exp Neurol. 2016;75:397–407.
pubmed: 26971127
pmcid: 5009476
doi: 10.1093/jnen/nlw014
Quattrini G, Pini L, Boscolo Galazzo I, et al. Microstructural alterations in the locus coeruleus-entorhinal cortex pathway in Alzheimer’s disease and frontotemporal dementia. Alzheimers Dement (Amst). 2024;16(1):e12513.
pubmed: 38213948
doi: 10.1002/dad2.12513
Grothe MJ, Heinsen H, Amaro E Jr, et al. Cognitive correlates of basal forebrain atrophy and Associated cortical hypometabolism in mild cognitive impairment. Cereb Cortex. 2016;26(6):2411–26.
pubmed: 25840425
doi: 10.1093/cercor/bhv062
Cantero JL, Zaborszky L, Atienza M. Volume loss of the Nucleus Basalis of Meynert is Associated with atrophy of innervated regions in mild cognitive impairment. Cereb Cortex. 2017;27(8):3881–9.
pubmed: 27371762
Liu AK, Chang RC, Pearce RK, et al. Nucleus basalis of meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease. Acta Neuropathol. 2015;129(4):527–40.
pubmed: 25633602
pmcid: 4366544
doi: 10.1007/s00401-015-1392-5
Li S. The β-adrenergic hypothesis of synaptic and microglial impairment in Alzheimer’s disease. J Neurochem. 2023;165(3):289–302.
pubmed: 36799441
doi: 10.1111/jnc.15782
Malatt C, Tagliati M. The role of the locus coeruleus/norepinephrine system in the pathogenesis of neurodegenerative disorders: an update. Curr Opin Neurol. 2022;35(2):220–9.
pubmed: 35175974
doi: 10.1097/WCO.0000000000001042
Gamage R, Wagnon I, Rossetti I, et al. Cholinergic modulation of glial function during aging and chronic neuroinflammation. Front Cell Neurosci. 2020;14:577912.
pubmed: 33192323
pmcid: 7594524
doi: 10.3389/fncel.2020.577912
Sibahi A, Gandhi R, Al-Haddad R, et al. Characterization of an automated method to segment the human locus coeruleus. Hum Brain Mapp. 2023;44(9):3913–25.
pubmed: 37126580
pmcid: 10203805
doi: 10.1002/hbm.26324
Mercan D, Heneka MT. The contribution of the Locus Coeruleus-Noradrenaline System Degeneration during the progression of Alzheimer’s Disease. Biology (Basel). 2022;11(12):1822.
pubmed: 36552331
Slater C, Liu Y, Weiss E, et al. The Neuromodulatory Role of the noradrenergic and Cholinergic Systems and their interplay in cognitive functions: a focused review. Brain Sci. 2022;12(7):890.
pubmed: 35884697
pmcid: 9320657
doi: 10.3390/brainsci12070890